Latanoprost And Timolol Accord Healthcare

Latanoprost and Timolol Maleate, the active ingredients in Latanoprost And Timolol Accord Healthcare, are a prostaglandin analog and beta‑blocker combination presented as an ophthalmic solution for ocular use. They treat primary open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost And Timolol Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance and reliable global distribution with comprehensive support for product registration, pharmacovigilance and post‑marketing surveillance.

Latanoprost and Timolol is indicated for the management of glaucoma and ocular hypertension, conditions characterized by elevated intra‑ocular pressure.

- Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow progression of optic nerve damage. - Ocular hypertension: lowers intra‑ocular pressure to prevent development of glaucoma. - Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions. - Pseudoexfoliative glaucoma: decreases intra‑ocular pressure to protect the optic nerve.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Redness of the conjunctiva. - Itching or mild allergic reaction on the ocular surface.

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelid or face. - Marked bradycardia or systemic hypotension. - Bronchospasm or worsening of asthma symptoms. - Uveitis or intra‑ocular inflammation.

Before using Latanoprost and Timolol, consider the following precautions: - Cardiovascular assessment: evaluate heart rate and blood pressure before initiating therapy. - Respiratory evaluation: avoid use in patients with asthma or severe chronic obstructive pulmonary disease. - Allergy screening: discontinue if signs of hypersensitivity such as rash or eye swelling appear. - Ocular surface disease: use with caution in patients with severe dry eye or corneal disorders. - Systemic beta‑blocker use: monitor for additive bradycardic effects when combined with oral beta‑blockers. - Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Latanoprost and Timolol may interact with other medicines as follows:

Major Interactions (Avoid): - Non‑selective systemic beta‑blockers (e.g., propranolol): may cause excessive bradycardia. - Sympathomimetic ophthalmic agents (e.g., epinephrine): can antagonize the intra‑ocular pressure‑lowering effect. - MAO inhibitors: may increase the risk of systemic hypotension when combined.

Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitor eye drops (e.g., dorzolamide): additive IOP‑lowering may require monitoring. - Anticholinergic eye drops: may affect pupil size and ocular comfort. - Systemic steroids: can reduce the efficacy of the prostaglandin component.